Ctrl

K

Elapegademase

Table of contents

Indications for use

Specific populations

Pregnancy and breastfeeding

Interactions

Class

Biologic agents

Subclass

Polypeptides

Substance name

Elapegademase, elapegademase-lvlr

Brand names

Recovi®

Common formulations

Injection

Indications for use

Labeled indications

Adults

•

Treatment of severe combined immunodeficiency due to adenosine deaminase deficiency

Children

•

Treatment of severe combined immunodeficiency due to adenosine deaminase deficiency

Pregnancy and breastfeeding

Pregnancy

All trimesters

•

Insufficient evidence. The manufacturer makes no recommendation regarding use during pregnancy.

Breastfeeding

Little information available on breastfeeding safety.

Unknown amount excreted in breastmilk.

Unknown drug levels in breastfed infants.

Acceptable for use during breastfeeding.

Unlikely excreted in breastmilk.

Unknown drug levels in breastfed infants.

Interactions

Drug(s)

Check Interactions

Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource